Previous studies with clinical cancer tissues have shown that DR4 is highly expressed in breast cancer patients with invasive ductal carcinoma 48 and its high expression in stage III adjuvant-treated colon cancer patients is associated with worse disease-free and overall survival 49. Here, TNFRSF10A is linked to malignant colon neoplasm.